CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for OTCPharm PAO (P) is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

OTCPharm PAO (P)
Likhachevskiy proyezd, d. 5 "B"
Phone: +7 4952211800p:+7 4952211800 DOLGOPUDNYI, 141700  Russian Federation Fax: +7 4952211802f:+7 4952211802
This company was Merged or Acquired on 4/3/2018.
Business Summary
OTCPharm PAO is a Russia-based company, which is primarily engaged in the pharmaceutical industry. The Company is mainly focused on the manufacture of over-the-counter (OTC) drugs in general therapeutic categories. It produces and sells drugs in a variety of categories, such as antiviral and immunomodulatory drugs; drugs for treatment of the nervous system diseases; drugs for treatment of the gastrointestinal tract diseases; drugs for treatment of the upper respiratory tract infection (URTI) and influenza; vitamins, minerals, herbal antioxidants; gynecological drugs; analgesic and nonsteroidal anti-inflammatory drugs; antifungal drugs; dermotropic drugs. The Company's product portfolio includes such brands as Arbidol, Amixin, Afobazol, Complivit, Codelac, Pentalgin and Flucostat, among others. Along with it, the Company produces and sells a range of prescription medicines, such as Termikon, Amixin, Azitrox among others.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/201812/31/2017Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board Viktor V.Kharitonin 46
General Director (CEO), Director Olga B.Mednikova 48 12/1/2013
Finance Director, Director Andrey V.Kuznetsov 44 8/1/2014
7 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 145,422,732 (As of 6/30/2018)
Fax Number: +7 4952211802


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023